Intimate Partner Violence (IPV) Health Partners
Web-based toolkit on ways for agencies to establish partnerships to address intimate partner violence (IPV).
Resource updated 07/17/2024
Web-based toolkit on ways for agencies to establish partnerships to address intimate partner violence (IPV).
Resource updated 07/17/2024
Resource updated 08/29/2022
Review of how RWHAP Part B programs develop, maintain, and evaluate service standards for all funded services, per Policy Clarification Notice (PCN) 16-02.
Resource updated 09/14/2023
Resource updated 05/15/2024
Intervention guide highlighting a patient navigation evidence-informed innovative model of care, focusing on the retention step of the HIV care continuum.
Resource updated 05/15/2024
Resource updated 05/15/2024
Review of how a community-based organization and an FQHC successfully engaged and retained transgender women of color in HIV care.
Resource updated 05/15/2024
Exploration of the unique challenges that older adults living with HIV may face and steps for agencies to consider in response.
Resource updated 10/11/2023
Innovative models for linking and retaining transgender women of color in HIV care.
Resource updated 10/18/2023
Resource for medical providers dealing with cultural challenges in serving Asian and Pacific Islander (API) patients living with HIV/AIDS.
Resource updated 09/14/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 07/18/2024
Online clinician training platform with evidence-based core competency training on HIV prevention, screening, diagnosis, care, and key populations.
Resource updated 07/18/2024
Curriculum for nurses teaching cultural competency in the care of LGBT older adults.
Resource updated 07/18/2024
Resource updated 07/18/2024
Resource updated 07/19/2024
Resource updated 07/19/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Resource updated 07/02/2024
Resource updated 07/02/2024
Resource from the RWHAP Best Practices Compilation updated on 06/11/2024